- About Us
- Participant Zone
- Learning Zone
Patients receiving anticoagulant therapy will have their POCT INR measured regularly to ensure that their INR is maintained within the appropriate range. This test may occasionally be used on a patient not taking anticoagulant medicine to check for a bleeding disorder, liver disease, Vitamin K deficiency or to ensure clotting ability before surgery.
Weqas has introduced new Point of Care (POC) INR EQA control material suitable for use with the Abbott i-STAT, Roche CoaguChek XS, XS Plus & XS Pro and Siemens Xprecia Stride instruments for POCT INR testing in secondary and primary care. The material is supplied in a ready to use dropper bottle, no prior treatment is required to activate the product. Result reporting and data analysis is provided via an interactive database at www.cuesee.com. The EQA samples are distributed to the Point of Care Co-ordinator in each trust, who is given a Group Administrator function and maintains the database for its own Trust. Result reporting and data analysis is provided via an interactive database, this system can readily accommodate primary care users and remote sites. The samples are supplied ready to use, no further preparation is required.
Samples per set: 1 x 0.5mL
|POCT INR Programme|
|Analyte||Approx. Range Covered|
|INR||1 - 4.5||Units|